Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical study on cefprozil fine granules].

M Ito1, E Takeda, Y Kuroda

  • 1Department of Pediatrics, School of Medicine, Tokushima University.

The Japanese Journal of Antibiotics
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of rBAT gene products in cystinuria.

International journal of urology : official journal of the Japanese Urological Association·2014
Same author

Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.

Kidney international·2006
Same author

Effect of late evening snack with rice ball on energy metabolism in liver cirrhosis.

European journal of clinical nutrition·2006
Same author

Generalized eruptive histiocytoma with rapid progression and resolution following exanthema subitum.

Clinical and experimental dermatology·2005
Same author

[Parathyroid hormone-mediated regulation of renal phosphate co-transporter].

Clinical calcium·2005
Same author

The Mediterranean vs the Japanese diet.

European journal of clinical nutrition·2004
Same journal

Evaluation of rapid measurement of Chlamydia trachomatis and Neisseria gonorrhoeae by using automatic gene analyzer "GENECUBE".

The Japanese journal of antibiotics·2018
Same journal

Investigations on yearly changes in tebipenem susceptibility of bacterial isolates from pediatric patients -A post-marketing surveillance of tebipenem pivoxil granules for pediatric.

The Japanese journal of antibiotics·2018
Same journal

Clinical analysis of the pediatric inpatients with lower respiratory tract infection due to human metapneumovirus.

The Japanese journal of antibiotics·2018
Same journal

Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 5 - Introduction of technology and knowledge on streptomycin production from the United States of Americat.

The Japanese journal of antibiotics·2018
Same journal

Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 4 - Enactment of requirements for individual antibiotic products.

The Japanese journal of antibiotics·2018
Same journal

Visual disturbance or central symptom like hallucination in patients treated voriconazole: report of six cases.

The Japanese journal of antibiotics·2018
See all related articles

Cefprozil (CFPZ) demonstrated 100% clinical efficacy in pediatric infectious diseases. This new cephem antibiotic showed excellent safety, with only one case of eosinophilia reported in 15 patients.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Pediatrics

Background:

  • Cefprozil (CFPZ) is a novel non-ester cephem antibiotic.
  • Pediatric infectious diseases require effective and safe treatment options.

Purpose of the Study:

  • To evaluate the clinical efficacy and safety of Cefprozil (CFPZ) in pediatric patients.
  • To assess the therapeutic outcomes and adverse effects of CFPZ in children.

Main Methods:

  • Oral administration of Cefprozil (CFPZ) at 18.5-41.7 mg/kg/day for 3-8 days.
  • Study included 15 pediatric patients (6 boys, 9 girls) aged 10 months to 11 years.
  • Clinical efficacy and side effects were monitored throughout the treatment period.

Main Results:

Related Experiment Videos

  • Cefprozil (CFPZ) achieved an overall clinical efficacy rate of 100%.
  • Excellent efficacy was observed in 3 patients, and good efficacy in 12 patients.
  • One patient experienced eosinophilia; no other adverse effects were reported.

Conclusions:

  • Cefprozil (CFPZ) is a highly effective antibiotic for treating infectious diseases in pediatric populations.
  • The safety profile of Cefprozil (CFPZ) in children is favorable, with minimal side effects observed.